Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
0.7260
+0.1112 (18.09%)
At close: Jul 21, 2025, 4:00 PM
0.7260
0.00 (0.00%)
Pre-market: Jul 22, 2025, 8:00 AM EDT
Salarius Pharmaceuticals Market Cap
Salarius Pharmaceuticals has a market cap or net worth of $1.54 million as of July 22, 2025. Its market cap has increased by 18.80% in one year.
Market Cap
1.54M
Enterprise Value
-141.74K
1-Year Change
18.80%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since January 29, 2015, Salarius Pharmaceuticals's market cap has decreased from $254.40M to $1.54M, a decrease of -99.39%. That is a compound annual growth rate of -38.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 1.30M | -51.85% |
| Dec 31, 2024 | 2.70M | 3.85% |
| Dec 29, 2023 | 2.60M | -25.71% |
| Dec 30, 2022 | 3.50M | -84.38% |
| Dec 31, 2021 | 22.40M | 23.76% |
| Dec 31, 2020 | 18.10M | 17.53% |
| Dec 31, 2019 | 15.40M | 156.67% |
| Dec 31, 2018 | 6.00M | -90.43% |
| Dec 29, 2017 | 62.70M | -33.93% |
| Dec 30, 2016 | 94.90M | -57.52% |
| Dec 31, 2015 | 223.40M | -12.19% |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.79B |
| Johnson & Johnson | 393.87B |
| AbbVie | 334.31B |
| Novo Nordisk | 287.38B |
| UnitedHealth Group | 256.40B |
| Novartis AG | 223.49B |
| Abbott Laboratories | 215.17B |
| AstraZeneca | 214.61B |